Optimizing Irinotecan Delivery Based on Circadian Rhythms
Author Information
Author(s): Ballesta Annabelle, Dulong Sandrine, Abbara Chadi, Cohen Boris, Okyar Alper, Clairambault Jean, Levi Francis
Primary Institution: INRIA Rocquencourt
Hypothesis
Can a combined experimental and mathematical approach optimize the circadian delivery of irinotecan based on patient molecular profiles?
Conclusion
The study found that optimal irinotecan exposure should occur over 3h30 to 6h30, starting 1h30 to 1h50 before the nadir of the patient's circadian rhythm.
Supporting Evidence
- Circadian timing significantly modifies the efficacy and toxicity of anticancer drugs.
- The study optimized irinotecan exposure based on circadian rhythms in Caco-2 cells.
- Mathematical modeling predicted that CPT11 bioactivation was the main determinant of its circadian rhythm.
Takeaway
This study shows that giving cancer medicine at the right time of day can make it work better and hurt less.
Methodology
The study used a combination of experimental data from Caco-2 colon cancer cells and a mathematical model to optimize irinotecan delivery.
Limitations
The study was conducted in vitro and may not fully represent in vivo conditions.
Participant Demographics
Caco-2 colon cancer cells were used as the model system.
Statistical Information
P-Value
0.05
Statistical Significance
p=0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website